We finance companies
that develop COVID-19 treatments and vaccines
to keep people safe from the virus
and save lives.
We help governments build hospitals
and buy new equipment
to stop the virus spreading
and to treat infections.
We lend money to businesses
so they can keep working
and pay salaries to their employees.
Since COVID-19 emerged,
we have decided to lend 56 billion euros
to companies affected by the crisis.